Melanoma May No Longer Be a Death Sentence

June 3 (Bloomberg) -- The next generation of experimental immune-boosting drugs from Merck, Bristol-Myers and Roche are producing such promising early results that doctors are openly speculating that some patients with the deadliest form of skin cancer may be cured. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)

Stoxx 600 Little Changed as Earnings Take Center Stage
59:34 - Bloomberg's Mark Barton breaks down the day's European trading on "Bloomberg Markets: European Close." (Source: Bloomberg)
  • OppenheimerFunds' CIO Wants Significant Fiscal Expansion
  • Magna CEO: Trade Barriers "Detrimental" To Auto Industry
  • JPMorgan Leads Bank Rally and Hits Record High